This most current twist within the Lykos Therapeutics saga threatens An important overhaul of the company’s system and course, with Musk ally and billionaire investor Antonio Gracias showing to desire to take the company back toward its nonprofit drug enhancement roots and a far more Doblinite philosophy.One of many important capabilities from th